Allen Casey J, Baldor Daniel J, Hanna Mena M, Namias Nicholas, Bullock M Ross, Jagid Jonathan R, Proctor Kenneth G
Am Surg. 2018 Mar 1;84(3):443-450.
After traumatic brain injury, decompressive craniectomy (DC) is a second-tier, late therapy for refractory intracranial hypertension. We hypothesize that early DC, based on CT evidence of intracranial hypertension, improves intracranial pressure (ICP) and cerebral perfusion pressure (CPP). From September 2008 to January 2015, 286 traumatic brain injury patients requiring invasive ICP monitoring at a single Level I trauma center were reviewed. DC and non-DC patients were propensity score matched 1:1, based on demographics, hemodynamics, injury severity score (ISS), Glasgow Coma Scale (GCS), transfusion requirements, and need for vasopressor therapy. Data are presented as M ± SD or median (IQR) and compared at P ≤ 0.05. The study population was 42 ± 17 years, 84 per cent male, ISS = 29 ± 11, GCS = 6(5), length of stay (LOS) = 32(40) days, and 28 per cent mortality. There were 116/286 (41%) DC, of which 105/116 (91%) were performed at the time of ICP placement. For 50 DC propensity matched to 50 non-DC patients, the midline shift was 7(11) versus 0(5) mm (P < 0.001), abnormal ICP (hours > 20 mm Hg) was 1(10) versus 8(16) (P = 0.017), abnormal CPP (hours < 60 mm Hg) was 0(6) versus 4(9) (P = 0.008), daily minimum CPP (mm Hg) was 67(13) versus 62(17) (P = 0.010), and daily maximum ICP (mm Hg) was 18(9) versus 22(11) (P < 0.001). However, LOS [33(37) versus 25(34) days], mortality (24 versus 30%), and Glasgow Outcome Score Extended [3.0(3.0) versus 3.0(4.0)] did not improve significantly. Early DC for CT evidence of intracranial hypertension decreased abnormal ICP and CPP time and improved ICP and CPP thresholds, but had no obvious effect on the outcome.
创伤性脑损伤后,减压性颅骨切除术(DC)是治疗难治性颅内高压的二线、晚期治疗方法。我们假设,基于颅内高压的CT证据进行早期DC可改善颅内压(ICP)和脑灌注压(CPP)。对2008年9月至2015年1月期间在一家一级创伤中心需要进行有创ICP监测的286例创伤性脑损伤患者进行了回顾性研究。根据人口统计学、血流动力学、损伤严重程度评分(ISS)、格拉斯哥昏迷量表(GCS)、输血需求和血管升压药治疗需求,对DC组和非DC组患者进行1:1倾向评分匹配。数据以M±SD或中位数(IQR)表示,并在P≤0.05水平进行比较。研究人群的年龄为42±17岁,男性占84%,ISS=29±11,GCS=6(5),住院时间(LOS)=32(40)天,死亡率为28%。286例患者中有116例(41%)接受了DC治疗,其中105例(91%)在放置ICP监测仪时进行了DC手术。对于50例接受DC治疗且倾向评分匹配的50例非DC治疗患者,中线移位分别为7(11)mm和0(5)mm(P<0.001),异常ICP(>